genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Genetic Disease Testing
Multiomics Approach Improves Diagnosis of Rare Disease, Methylmalonic Aciduria
Base Editing
Zinc Finger Design AI Tool Opens Door to Large-Scale Gene Therapies
Cancer
Multidrug Nanoparticle Platform Improves Drug Delivery against Cancer
Cancer
Cancer’s Capacity to Resist Treatment Thwarted
Animal Models
Microbiome and its Metabolites Promote Endometriosis in Animal Model
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Artificial Intelligence
Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block
Antibodies
Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis
Bioprocessing
Cell and Gene Therapy Scale-Up Challenges
Bioprocessing
Making Molecules Instead of Growing Them
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Eli Lilly
Eli Lilly
10x Genomics
A-Lists
AgBio
Age-Related Disorders
Aging
AGTC
alcohol
Alexandria Real Estate Equities
Allergic Diseases
Application Notes
Artificial Intelligence
Autoimmune Disorders
Bacterial Diseases
Bacteriophage
Base Editing
Bayer
Biodefense/Bioterrorism
Bioethics
Biomarker Discovery
BioNTech
BioPerspectives
Blockchain
Blood Disorders
Boehringer Ingelheim
Bone disorders
Brexit
Bristol-Myers Squibb
Cardiovascular Disease
Careers
Celgene
Cell Analysis
Cell Biology
Cell Culture
Cell Line Development
Cell Signaling
Cell Therapy
Cellular Analysis
China
Chromatography
Circadian Rhythm
Commentary
Compound Synthesis
Computational Biology
Computer Simulation
COVID-19 Candidates
CRISPR
CRISPR/Cas9
Danaher
Developmental Disorders
DNA Repair
Drug Resistance
Ear Disorders
Economic development
Education and training
Electrophoresis
Eli Lilly
Employment Trends
Endocrine Disorders
Evolution
Extracellular Matrix
Eye Disorders
Fill and Finish
Financing
Flow Cytometry
Forensics
Fungal Diseases
Gastrointestinal Disorders
GEN 40
GEN Edge
Genentech
Genetic Disease Testing
Genetics
Glycan Analysis
Glycoproteins
GWAS
Hematologic Conditions
Histology
HPLC
Hypertension
Imaging
Immunoassay
Immunochemistry
Immunology
In-vitro Fertilization
Industry News
Inflammatory Diseases
Information Management
Insights
interleukin
Ion Channels
Kidney Diseases
Kinases
Literature Review
Liver Diseases
Lung Cancer
Lung Diseases
Magazine
Marijuana
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Alzheimers
StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
Gene Therapy
Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus
Alzheimers
StockWatch: Biogen Shares Rebound as Alzheimer’s Drug Aces Phase III Trial
Drug Discovery
Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring
Cell Therapy
Sweet Spot: CRISPR Therapeutics, ViaCyte Dose First Patient with Cell Therapy for Type 1 Diabetes
Alzheimers
Jabbing at Alzheimer’s: AC Immune Takes Precision Approach to Vaccines
RNA
Lilly Plans $700M Genetic Medicine Institute in Boston
Coronavirus
FDA Grants Lilly EUA for COVID-19 Antibody Bebtelovimab
Gastrointestinal Disorders
Inflection Point: Abivax Challenges Pharma Giants in Ulcerative Colitis
Financing
EY Firepower Report: Biopharmas Choosing Collaborations over M&A
T Cells
Jurassic Ambitions: TRexBio Targets Tregs with Janssen Collaboration
Gene Expression
Signal Indications: Foghorn Targets Cancer with Up-to-$1.7B Lilly Partnership, and Looks...
Eli Lilly
Lilly, Kumquat Launch Up-to-$2B Immuno-Oncology Collaboration
Eli Lilly
U.S. OKs EUA for Genentech’s Actemra vs. COVID-19; Halts Distribution of...
Eli Lilly
AbCellera, Lilly Advance Next-Generation Antibody vs. COVID-19
1
2
3
Page 1 of 3
Scroll Up
Login
Subscribe